Qianjiang Yongan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 196.64 million compared to CNY 311.17 million a year ago. Net income was CNY 28.68 million compared to CNY 14.98 million a year ago.

Basic earnings per share from continuing operations was CNY 0.0973 compared to CNY 0.0508 a year ago. Diluted earnings per share from continuing operations was CNY 0.0973 compared to CNY 0.0508 a year ago.